JP2003265420A - Hemodynamometer with arterial pressure pulse wave analyzing function using brachium pressurizing method - Google Patents
Hemodynamometer with arterial pressure pulse wave analyzing function using brachium pressurizing methodInfo
- Publication number
- JP2003265420A JP2003265420A JP2002072865A JP2002072865A JP2003265420A JP 2003265420 A JP2003265420 A JP 2003265420A JP 2002072865 A JP2002072865 A JP 2002072865A JP 2002072865 A JP2002072865 A JP 2002072865A JP 2003265420 A JP2003265420 A JP 2003265420A
- Authority
- JP
- Japan
- Prior art keywords
- blood pressure
- pressure
- pulse wave
- basal
- cuff
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 18
- 230000004872 arterial blood pressure Effects 0.000 title description 4
- 230000036772 blood pressure Effects 0.000 claims abstract description 113
- 206010020772 Hypertension Diseases 0.000 claims abstract description 41
- 230000035487 diastolic blood pressure Effects 0.000 claims abstract description 16
- 239000012530 fluid Substances 0.000 claims abstract description 12
- 208000005434 White Coat Hypertension Diseases 0.000 claims description 22
- 238000001514 detection method Methods 0.000 claims description 22
- 230000035488 systolic blood pressure Effects 0.000 claims description 10
- 238000000491 multivariate analysis Methods 0.000 claims description 6
- 230000009467 reduction Effects 0.000 claims description 3
- 238000009530 blood pressure measurement Methods 0.000 abstract description 12
- 230000008859 change Effects 0.000 abstract description 7
- 238000005259 measurement Methods 0.000 description 14
- 230000006837 decompression Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 102100029860 Suppressor of tumorigenicity 20 protein Human genes 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 101000585359 Homo sapiens Suppressor of tumorigenicity 20 protein Proteins 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 102100035353 Cyclin-dependent kinase 2-associated protein 1 Human genes 0.000 description 1
- 101000661807 Homo sapiens Suppressor of tumorigenicity 14 protein Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000001765 aortic valve Anatomy 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、血圧計、特に、カ
フ帯を用い、脈波の波形変化に基づいて血圧を決定する
血圧計測時に、一定時間圧力をホ−ルドして脈波を検出
して基底血圧測定及び白衣性高血圧の判断可能な血圧計
に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a sphygmomanometer, and in particular, a cuff band is used to detect the pulse wave by holding the pressure for a certain period of time when measuring the blood pressure based on the change in the waveform of the pulse wave. And a sphygmomanometer capable of measuring basal blood pressure and determining white coat hypertension.
【0002】[0002]
【従来の技術】血圧は一日のうちで変化しており、十万
回以上の血圧値(収縮期血圧、拡張期血圧、平均血圧)
が存在する。最近、一日のうちで最も低くなる除波睡眠
中の血圧である基底血圧 が臓器障害、および、心肥大
と強く関係していることが明らかとなっている。2. Description of the Related Art Blood pressure changes during the day, and the blood pressure value is 100,000 or more times (systolic blood pressure, diastolic blood pressure, mean blood pressure).
Exists. Recently, it has been revealed that the basal blood pressure, which is the lowest blood pressure during wave-removing sleep in a day, is strongly associated with organ damage and cardiac hypertrophy.
【0003】従来、基底血圧の測定は、カフを用いた血
圧計を24時間装着し測定するか、動脈にAラインを2
4時間留置して観血血圧計にて測定する方法が行われて
いた。いずれも患者の負担が大きくか、または、危険度
が大きい侵襲度の高い方法である。また、高血圧の診療
において、診療室での血圧測定時、血圧が正常であって
も、医師または看護婦の白衣を見ると不安と緊張により
血圧が高くなる疑似高血圧である白衣性高血圧を呈する
患者が約30%存在しており、高血圧治療上配慮が必要
であることが知られている。この白衣性高血圧が疑われ
る場合には、しばらく休息させ、落ちついた状態で再度
測定するか、基底血圧の測定と同様に、24時間血圧計
を装着して測定するかして、白衣性高血圧の検査を行っ
ていた。Conventionally, the basal blood pressure is measured by wearing a blood pressure monitor using a cuff for 24 hours, or measuring the A line on the artery by 2 lines.
A method in which the blood vessel was left for 4 hours and measured with an open blood pressure monitor was used. All of these methods have a high burden on the patient or are highly risky and highly invasive. Also, in the treatment of hypertension, patients with white-coating hypertension, which is pseudo-hypertension in which blood pressure is high due to anxiety and tension when looking at the white coat of the doctor or nurse even when blood pressure is normal when measuring blood pressure in the clinic. Is present in about 30%, and it is known that consideration is necessary in treating hypertension. If this white coat hypertension is suspected, rest it for a while and measure it again in a calm state, or, like measuring the basal blood pressure, wear a 24-hour sphygmomanometer and measure the white coat hypertension. I was conducting an inspection.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、基底血
圧の測定に当たり、カフを用いた血圧計を24時間装着
する場合、血圧計を携帯したまま、日常活動を行いかつ
睡眠をを取らなければならず拘束感が大きい、15〜3
0分毎の測定時には腕を締め付けられる、ポンプ加圧音
により周囲の人に気づかれる等、肉体的にも、精神的に
も患者負担が非常に大きいという問題がある。また、血
圧測定精度においても、睡眠時の上腕の締め付け、加圧
ポンプ音により安眠が妨げられ血圧が高くなる問題、ま
た、歩行、作業等によるア−チファクトの発生及び、睡
眠時の腕の締め付け、加圧ポンプの騒音による体動の発
生がア−チファクトとなり正確な血圧測定が妨げられる
問題がある。また、カフを用いた血圧計の場合には、そ
の負担の大きさから人道的に一日に72回〜96回程度
が測定回数の限界であり、10万回に較べて測定回数が
著しく少なく、精度が悪いという問題がある。一方、観
血血圧測定においては、日に10万回の血圧値は測れる
利点はあるが、Aラインを動脈に入れ、留置しなければ
ならず、動脈損傷、感染、クロットの危険があり管理が
行き届いた医療機関内でしか行えず、通常の高血圧診療
には使えないという問題があった。However, in measuring the basal blood pressure, when wearing a sphygmomanometer using a cuff for 24 hours, it is necessary to carry out daily activities and sleep while carrying the sphygmomanometer. Great sense of restraint 15-3
At the time of measurement every 0 minutes, there is a problem that the patient's burden is very large physically and mentally such that the arm is tightened and the surrounding people are noticed by the sound of pump pressurization. Further, also in terms of blood pressure measurement accuracy, tightening of the upper arm during sleep, a problem that sleep pressure is hampered to prevent sleep, resulting in high blood pressure, and occurrence of artifacts due to walking, working, etc., and tightening of the arm during sleep. However, there is a problem that the generation of body movement due to the noise of the pressurizing pump becomes an artifact, which hinders accurate blood pressure measurement. Further, in the case of a blood pressure monitor using a cuff, the number of measurements is humanely limited to 72 to 96 times a day due to the burden, and the number of measurements is significantly smaller than 100,000. However, there is a problem of poor accuracy. On the other hand, in open blood pressure measurement, there is an advantage that the blood pressure value can be measured 100,000 times a day, but it is necessary to insert the A line into the artery and leave it in place, and there is a risk of arterial damage, infection, and clot, and management is difficult. There was a problem that it could only be done in a well-kept medical institution and could not be used for normal hypertension treatment.
【0005】また、通常の高血圧診療において、白衣性
高血圧が疑われた場合の確認検査には、患者が落ちつく
まで待って再度血圧測定を行う必要があり、診療治療に
時間を要する。また、カフを用いた血圧計を24時間装
着し検査する場合には、基底血圧の測定と同様の問題が
発生していた。Further, in the usual hypertensive medical care, it is necessary to wait until the patient is calm and to measure the blood pressure again in the confirmation test when the white coat hypertension is suspected, which requires time for medical treatment. In addition, when a blood pressure monitor using a cuff is worn for 24 hours for inspection, the same problem as in the measurement of basal blood pressure occurs.
【0006】本発明は、上記問題点を解決するためにな
されたもので、カフ帯を用い、脈波の波形変化に基づい
て血圧を決定する血圧計測時に、一定時間圧力をホ−ル
ドして脈波を検出して基底血圧測定及び白衣性高血圧の
判断可能な血圧計を提供することを目的とする。The present invention has been made in order to solve the above-mentioned problems, and uses a cuff band to hold the pressure for a certain period of time when measuring the blood pressure to determine the blood pressure based on the waveform change of the pulse wave. An object of the present invention is to provide a sphygmomanometer capable of detecting a pulse wave and measuring basal blood pressure and determining white coat hypertension.
【0007】[0007]
【課題を解決するための手段】上記課題を解決するため
に、本発明の血圧計は、カフ帯及びカフ帯内の流体を加
圧する加圧手段と減圧する減圧手段、一定圧にホ−ルド
する圧力ホ−ルド手段と、カフ帯内の流体圧を検出する
圧力検出手段と、カフ帯装着部位の脈波を検出する脈波
検出手段と、圧力検出手段で検出した流体圧と脈波検出
手段で検出した脈波に基づいて血圧値を決定する血圧決
定手段と、カフ圧を血圧決定手段で決定した拡張期血圧
より所定圧(約10mmHg)低い一定圧にホールドして
いる時の脈波検出手段からの出力より基底脈拍数を計算
する基底脈拍数計算手段と、基底血圧を計算する基底血
圧計算手段と、白衣性高血圧判断手段を有することを特
徴としている。ここで、白衣性高血圧とは、医者,看護
婦等の医療従事者が患者の血圧を測定する時に、通常時
の血圧よりも高く測定され、その血圧値が高血圧領域に
なることをいう。In order to solve the above-mentioned problems, the blood pressure monitor of the present invention comprises a pressurizing means for pressurizing a cuff band and a fluid in the cuff band, a depressurizing means for depressurizing the cuff band, and a hold at a constant pressure. Pressure hold means, pressure detecting means for detecting the fluid pressure in the cuff band, pulse wave detecting means for detecting the pulse wave of the cuff band attachment site, and fluid pressure and pulse wave detection by the pressure detecting means A blood pressure determining means for determining a blood pressure value based on the pulse wave detected by the means, and a pulse wave when the cuff pressure is held at a constant pressure lower by a predetermined pressure (about 10 mmHg) than the diastolic blood pressure determined by the blood pressure determining means. It is characterized by having a basal pulse rate calculation means for calculating a basal pulse rate from the output from the detection means, a basal blood pressure calculation means for calculating a basal blood pressure, and a white coat hypertension determination means. Here, white coat hypertension means that when a medical worker such as a doctor or a nurse measures the blood pressure of a patient, the blood pressure is measured higher than the normal blood pressure, and the blood pressure value is in the high blood pressure region.
【0008】また、基底脈拍数計算手段が、脈波間隔測
定手段の出力と、脈波形状パラメ−タ測定手段の出力
と、アップストロ−ク検出手段の出力と、血圧決定手段
の出力を用いることを特徴とする。また、基底血圧値計
算手段が、基底脈拍数計算手段の出力と、波形形状パラ
メ−タ検出手段の出力と、脈波間隔測定手段の出力と、
血圧決定手段の出力とアップストロ−クタイム検出手段
の出力を用いることを特徴とする。The basal pulse rate calculating means uses the output of the pulse wave interval measuring means, the output of the pulse wave shape parameter measuring means, the output of the upstroke detecting means, and the output of the blood pressure determining means. It is characterized by Further, the basal blood pressure value calculating means, the output of the basal pulse rate calculating means, the output of the waveform shape parameter detecting means, the output of the pulse wave interval measuring means,
The output of the blood pressure determining means and the output of the up stroke time detecting means are used.
【0009】また、白衣性高血圧判断手段が、基底血圧
計算手段の出力と、ある規定値を比較して白衣性高血圧
を検査することを特徴とする。また、波形形状パラメ−
タ検出手段として、脈波ピ−クからボトムに到る減衰特
性を検出することを特徴とする。Further, the white-coating hypertension determining means compares the output of the basal blood pressure calculating means with a certain prescribed value to test the white-coating high blood pressure. Also, the waveform shape parameter
The data detection means is characterized by detecting the attenuation characteristic from the pulse wave peak to the bottom.
【0010】また、基底脈拍数計算手段は、臨床にて収
集した本考案の血圧計により検出した脈波波形および別
の方法で検出した基底血圧デ−タを多変量解析すること
により複数の定数を設定する手段を含むことを特徴とす
る。また、基底血圧値計算手段は、臨床にて収集した本
考案の血圧計により検出した脈波波形および別の方法で
検出した基底血圧デ−タを多変量解析することにより複
数の定数を設定する手段を含むことを特徴とする。Further, the basal pulse rate calculating means uses a multivariate analysis of pulse wave waveforms detected by the sphygmomanometer of the present invention collected clinically and basal blood pressure data detected by another method to obtain a plurality of constants. It is characterized by including a means for setting. The basal blood pressure value calculating means sets a plurality of constants by multivariate analysis of the pulse wave waveform detected by the sphygmomanometer of the present invention collected clinically and the basal blood pressure data detected by another method. It is characterized by including means.
【0011】また、一定圧にホ−ルドしているときにの
脈波検出手段が、減圧を中止してから、脈波検出を開始
するまでに脈波を検出しない所定の時間を設けたことを
特徴とする。また、一定圧にホ−ルドしている時間が、
所定秒(10秒)以内であることを特徴とする。また、基
底血圧値が収縮期血圧の基底血圧と、拡張期血圧の基底
血圧と、平均血圧の基底血圧であることを特徴とする。Further, the pulse wave detecting means when the pressure is held at a constant pressure is provided with a predetermined time during which the pulse wave is not detected after the pressure reduction is stopped and before the pulse wave detection is started. Is characterized by. Also, the time to hold at a constant pressure,
It is characterized by being within a predetermined second (10 seconds). Further, the basal blood pressure value is a basal blood pressure of systolic blood pressure, a basal blood pressure of diastolic blood pressure, and a basal blood pressure of average blood pressure.
【0012】このような構成の上腕加圧法による動脈圧
脈波解析機能付き血圧計では、カフを用いる通常の血圧
測定と同時に、基底血圧の測定、白衣性高血圧の検査が
行えるので、短時間に、患者の負担が小さい、適切な血
圧診断に行える。In the sphygmomanometer with the arterial pressure / pulse wave analysis function by the brachial pressurization method having such a configuration, the basal blood pressure and the white coat hypertension can be measured at the same time as the normal blood pressure measurement using the cuff, so that it can be performed in a short time. The patient's burden is small, and it is possible to perform an appropriate blood pressure diagnosis.
【0013】[0013]
【発明の実施の形態】以下、本発明を添付図面を参照し
てより詳細に説明する。DETAILED DESCRIPTION OF THE INVENTION The present invention will now be described in more detail with reference to the accompanying drawings.
【0014】図1は、この発明に係わる上腕加圧法によ
る動脈圧脈波解析機能付き血圧計のブロック図である。
1は阻血用のカフ(大カフ)、2は脈波検出用のカフ
(小カフ)、5は阻血用カフの圧力と脈波検出用カフの
脈信号を検出する圧力センサ−(脈波検出手段)、6はカ
フを加圧する加圧ポンプ(加圧手段)でMPU10に制御
されている。7はカフ1,2内の空気を定速で微速排
気、かつ、排気ストップ、かつ、完全開状態にて急速排
気する排気兼定速減圧バルブ(排気/減圧手段)でMPU
10に制御されている。FIG. 1 is a block diagram of a sphygmomanometer with an arterial pressure pulse wave analysis function by the upper arm pressurization method according to the present invention.
1 is a blood cuff (large cuff), 2 is a pulse wave detection cuff (small cuff), 5 is a pressure sensor for detecting the pressure of the ischemic cuff and the pulse signal of the pulse wave detection cuff (pulse wave detection Means) and 6 are pressurizing pumps (pressurizing means) for pressurizing the cuff, which are controlled by the MPU 10. An MPU is an exhaust / constant-speed decompression valve (exhaust / decompression means) for exhausting the air in the cuffs 1 and 2 at a constant speed, a slight speed, and an exhaust stop, and rapidly exhausting it in a fully opened state.
It is controlled to 10.
【0015】4は脈波検出用カフが検出する脈波を減衰
するための流体抵抗である。3は脈波検出用カフ2と流
体抵抗4と圧力センサ−5を接続する第1の配管であ
る。8は阻血用カフ1と流体抵抗4と加圧ポンプ6と排
気兼低速減圧バルブ7を接続する第2の配管である。9
は圧力センサ−の出力より、カフ圧力検出、脈波検出に
は必要ない周波数をカットするフィルタであり、その出
力はMPU10に入力される。10は測定開始停止、加
圧・減圧・排気・排気停止、圧力測定、脈波検出、血圧脈
拍数測定、基底血圧測定、白衣性高血圧検出、血圧・脈
拍数・白衣性高血圧判断結果を表示器12に表示・制御
する機能を行うMPUである。12はLCDまたは、L
ED、またはプラズマ表示器である。11はMPU10
内にあり、MPU10で1〜30mS毎に検出された脈
波デ−タ、圧力、血圧値、脈拍数を記憶するメモリ−
(記憶手段)である。13は測定を開始する開始スイッチ
でありこの動作はMPU10に入力される。14は測定
を停止する停止スイッチであり、測定途中で装置を停止
するときに用いる。このスイッチ動作はMPU10に入
力される。図示しないが、装置を動かす内蔵電池を有す
る。Reference numeral 4 is a fluid resistance for attenuating the pulse wave detected by the pulse wave detecting cuff. Reference numeral 3 is a first pipe for connecting the pulse wave detecting cuff 2, the fluid resistance 4 and the pressure sensor-5. Reference numeral 8 is a second pipe that connects the cuff 1 for blood flow prevention, the fluid resistance 4, the pressurizing pump 6, and the exhaust / low-speed decompression valve 7. 9
Is a filter that cuts a frequency unnecessary for cuff pressure detection and pulse wave detection from the output of the pressure sensor, and its output is input to the MPU 10. 10 is a display for displaying the measurement start / stop, pressurization / decompression / exhaust / exhaust stop, pressure measurement, pulse wave detection, blood pressure pulse rate measurement, basal blood pressure measurement, lab coat hypertension detection, blood pressure / pulse rate / lab coat hypertension determination result. It is an MPU that performs the function of displaying and controlling on 12. 12 is LCD or L
ED or plasma display. 11 is MPU10
A memory for storing pulse wave data, pressure, blood pressure, and pulse rate detected every 1 to 30 mS by the MPU 10.
(Storage means). Reference numeral 13 is a start switch for starting measurement, and this operation is input to the MPU 10. Reference numeral 14 denotes a stop switch for stopping the measurement, which is used when stopping the device during the measurement. This switch operation is input to the MPU 10. Although not shown, it has a built-in battery for operating the device.
【0016】図2は、上腕加圧法による動脈圧脈波解析
機能付き血圧計の動作フロ−チャ−トである。ステップ
ST1にて開始SW13が押されると、ステップST2
にて圧力センサ−5のゼロセットが行われ、ステップS
T3にてカフ圧力測定、表示器12への表示が開始され
る。ステップST4にて、排気兼定速減圧バルブ7が閉
じられ加圧ポンプがONされ、大カフ、小カフにエア−
が供給され大カフにより部位が加圧される。ステップS
T5でカフ圧が収縮期血圧より高い設定圧まで加圧され
たかが判定される。設定圧になったらステップST6で
加圧ポンプ6を止め、排気兼定速排気バルブ7が制御さ
れカフ圧を所定(3〜6mmHg/秒)のスピ−ドで減圧
開始する。ステップST7で脈波検出を行う。脈波が検
出されるとステップST8で検出された脈波の例えば振
幅とカフ圧がペアでメモリ−11に記憶される。ステッ
プST9で脈波振幅が最大値を超えたかが検出され、最
大値を超えない場合にはステップST7に戻り、脈波検
出を繰り返す。脈波振幅が最大値を越えた場合にはステ
ップST10の加圧不足の判定に進む。FIG. 2 is an operation flow chart of a sphygmomanometer with an arterial pressure pulse wave analysis function by the upper arm pressurization method. When the start SW 13 is pressed in step ST1, step ST2
In step S, zero setting of the pressure sensor-5 is performed.
At T3, cuff pressure measurement and display on the display 12 are started. In step ST4, the exhaust / constant-speed decompression valve 7 is closed, the pressurizing pump is turned on, and air is supplied to the large and small cuffs.
Is supplied and the site is pressurized by the large cuff. Step S
At T5, it is determined whether the cuff pressure has been increased to a set pressure higher than the systolic blood pressure. When the set pressure is reached, the pressurizing pump 6 is stopped in step ST6, and the exhaust / constant speed exhaust valve 7 is controlled to start depressurizing the cuff pressure at a predetermined speed (3 to 6 mmHg / sec). Pulse wave detection is performed in step ST7. When the pulse wave is detected, for example, the amplitude and the cuff pressure of the pulse wave detected in step ST8 are stored in the memory-11 as a pair. In step ST9, it is detected whether the pulse wave amplitude exceeds the maximum value, and if it does not exceed the maximum value, the process returns to step ST7 and the pulse wave detection is repeated. If the pulse wave amplitude exceeds the maximum value, the process proceeds to step ST10 for determination of insufficient pressurization.
【0017】メモリ−11に記憶している第1番目の脈
波振幅値と脈波の最大振幅値に0.5を掛けた値とが比
較され、第1番目の脈波振幅が大きい場合加圧不足と判
定され、ステップST32にて、たとえば、先の設定圧
+所定圧(40mmHg)高い圧力に設定圧を換えかつ排
気兼定速排気バルブを閉じ、ステップST4に戻って加
圧ポンプ6がONされ再加圧される。ステップST10
にて加圧不足でない場合には、ステップST11に進
み、メモリ11に記憶された脈波振幅のデ−タより血圧
決定手段にて振幅デ−タの変化の大きいポイントを検出
して収縮期血圧(SYS)を決定する。The first pulse wave amplitude value stored in the memory 11 is compared with the value obtained by multiplying the maximum pulse wave amplitude value by 0.5, and when the first pulse wave amplitude is large, it is added. It is determined that the pressure is insufficient, and in step ST32, for example, the set pressure is changed to a pressure higher than the set pressure + predetermined pressure (40 mmHg) and the exhaust / constant speed exhaust valve is closed. It is turned on and repressurized. Step ST10
If the pressurization is not insufficient at step ST11, the systolic blood pressure is detected by the blood pressure determining means detecting a point where the change in the amplitude data is large from the pulse wave amplitude data stored in the memory 11. (SYS) is determined.
【0018】続いて、ステップST12にて脈波検出を
行いステップST13にて、たとえば振幅とカフ圧をメ
モリ11に記憶にする。ステップST14にてメモリ−
11に記憶された脈波振幅より血圧決定手段にて脈波振
幅のデ−タを検索し変化が小さくなったポイントを検出
し拡張期血圧(DIA)を決定する。ステップST14
にて拡張期血圧該当する脈波振幅変化が無い場合にはス
テップST12の前にもどり脈波検出を続ける。ステッ
プST14にて拡張期血圧が検出されたら、ステップS
T15にて拡張期血圧より所定圧(約10mmHg)まで
カフ圧が下がったか否か確認され、確認された場合には
排気兼定速排気バルブを閉じ、ステップST16にて減
圧をストップする。Subsequently, the pulse wave is detected in step ST12, and the amplitude and the cuff pressure are stored in the memory 11 in step ST13. Memory at step ST14
The blood pressure determining means searches the data of the pulse wave amplitude from the pulse wave amplitude stored in 11, and the point where the change becomes small is detected to determine the diastolic blood pressure (DIA). Step ST14
If there is no change in the pulse wave amplitude corresponding to the diastolic blood pressure, return to step ST12 and continue pulse wave detection. When diastolic blood pressure is detected in step ST14, step S
At T15, it is confirmed whether or not the cuff pressure has dropped from the diastolic blood pressure to a predetermined pressure (about 10 mmHg). If it is confirmed, the exhaust / constant speed exhaust valve is closed, and the pressure reduction is stopped at step ST16.
【0019】ステップST17にてタイマ−がスタ−ト
し、カフ圧が安定するまで所定秒(約2秒間)脈波測定を
中止する。ステップST18にて約2秒が経ったら、ス
テップST19にてタイマ−をリセットする。ステップ
ST20にて脈波検出、メモリ−11への記憶を開始
し、ステップST21にて鬱血の影響が小さい10秒以
下の短い減圧ストップ時間が望ましく、本実施例では約
5秒が経過するまでステップST20にて、脈波検出、
記憶を続ける。ステップST21にて約5秒(デ−タ数
n)が経過したら、ステップST22にて排気兼定速排
気バルブを全開にして、カフ内空気を排気する。In step ST17, the timer is started and the pulse wave measurement is stopped for a predetermined second (about 2 seconds) until the cuff pressure stabilizes. After about 2 seconds have passed in step ST18, the timer is reset in step ST19. In step ST20, pulse wave detection and storage in the memory-11 are started, and in step ST21, a short decompression stop time of 10 seconds or less at which the influence of congestion is small is desirable. In the present embodiment, steps are performed until about 5 seconds elapse. In ST20, pulse wave detection,
Continue to remember. When about 5 seconds (data number n) have elapsed in step ST21, the exhaust / constant speed exhaust valve is fully opened in step ST22 to exhaust the air in the cuff.
【0020】アップストロ−ク検出手段であるステップ
ST23,ステップST24にてアップストロ−クタイ
ムU0(n)を計算する。ステップST23により血圧決
定手段の出力より収縮期血圧と拡張期血圧の比率m=L
OG(Ps/Pd)を計算する。ステップST24にて
基底血圧時のアップストロ−クタイムU0(n)を臨床デ
−タを基に多変量解析により求めた式U0(n)=0.4
5*m1/2 −0.1にこのmを代入して計算する。
ステップST25にて基底血圧発生時の脈拍数である基
底脈拍数を基底脈拍数計算手段により計算する。The upstroke time U 0 (n) is calculated in steps ST23 and ST24 which are upstroke detecting means. In step ST23, the ratio m = L of systolic blood pressure and diastolic blood pressure is calculated from the output of the blood pressure determining means.
Calculate OG (Ps / Pd). In step ST24, the upstroke time U 0 (n) at the time of basal blood pressure is calculated by multivariate analysis based on clinical data, and is expressed as U 0 (n) = 0.4.
Calculation is carried out by substituting m for 5 * m 1/2 -0.1.
In step ST25, the basal pulse rate, which is the pulse rate when the basal blood pressure occurs, is calculated by the basal pulse rate calculation means.
【0021】図3に基底脈拍数計算手段のフロ−チャ−
ト詳細を示す。まず、波形形状パラメ−タ検出手段であ
るステップST2501〜ステップST2509にて、
脈波の減衰特性である脈波形状パラメ−タA(n)を求め
る。ステップST2501にてステップST20で記憶
された脈波デ−タn個より体動、不整脈を除去する。ス
テップST2502にて検出できた脈波の上行脚の最大
値をピ−クポイントtp(n)として、同様に検出した下降
脚の最低値をボトムポイントtb(n)として記憶する。
脈波間隔測定手段であるステップST2505にてステ
ップST2502に記憶されたピ−クポイントtp (n)
間より脈波周期(RR)を計算し記憶する。各脈波毎
に、脈波ピ−クポイントtp(n)からデ−タ変化を検索し
て、心臓の大動脈弁が閉じることにより生ずる切痕ポイ
ントta(n)を検出し記憶する。ステップST2507に
よりta(n)から脈波ボトムまでのデ−タの内から規定数
デ−タ(15ポイント;サンプリング10mSの時)を
抜き出す。FIG. 3 is a flowchart of the basal pulse rate calculating means.
Show details. First, in steps ST2501 to ST2509 which are waveform shape parameter detecting means,
A pulse wave shape parameter A (n), which is a pulse wave attenuation characteristic, is obtained. In step ST2501, body movements and arrhythmias are removed from the n pulse wave data stored in step ST20. The maximum value of the ascending leg of the pulse wave detected in step ST2502 is stored as the peak point tp (n), and the similarly detected minimum value of the descending leg is stored as the bottom point tb (n).
In step ST2505 which is a pulse wave interval measuring means, the peak point tp (n) stored in step ST2502.
The pulse wave period (RR) is calculated from the interval and stored. For each pulse wave, a data change is searched from the pulse wave peak point tp (n) to detect and store the notch point ta (n) caused by the closing of the aortic valve of the heart. In step ST2507, a specified number of data (15 points; when sampling is 10 mS) is extracted from the data from ta (n) to the pulse wave bottom.
【0022】ステップST2508により、脈波ピ−ク
ポイントの大きさをステップST11で検出した収縮期
血圧値(Ps)、脈波ボトムポイントの大きさを拡張期
血圧値(Pd)に換算し、ステップST2507にて抜
き出したデ−タを圧力値に変換する。ステップST25
08で換算したデ−タより単一指数回帰曲線(Pd*E
XP(A(RR−u))をステップST2509にて求
め、脈波形形状パラメ−タA(n)を検出する。脈波形形
状パラメ−タA(n)の検出に当たっては計算した回帰曲
線の相関係数が80以上の脈波のみを用いることが望ま
しい。ステップST2510にて、基底血圧発生時の基
底脈拍数RR0(n)=0.126/A+(U0/A)1/2+
U0 を計算する。ステップST2511にて脈波毎
の基底脈拍数RR0(n)をメモリ−11に記憶する。こ
れをST20に記録した脈波について繰り返す。ST2
514にて計算した各脈波の基底脈拍数の平均を取り基
底脈拍数RR0Eを求める。In step ST2508, the size of the pulse wave peak point is converted into the systolic blood pressure value (Ps) detected in step ST11, and the size of the pulse wave bottom point is converted into the diastolic blood pressure value (Pd). The data extracted in ST2507 is converted into a pressure value. Step ST25
The single exponential regression curve (Pd * E
XP (A (RR-u)) is obtained in step ST2509 to detect the pulse waveform shape parameter A (n). In detecting the pulse waveform shape parameter A (n), it is desirable to use only the pulse wave having the calculated regression curve correlation coefficient of 80 or more. In Step ST2510, the basal pulse rate RR 0 (n) = 0.126 / A + (U 0 / A) 1/2 + when the basal blood pressure occurs
Calculate U 0 . In step ST2511, the basal pulse rate RR 0 (n) for each pulse wave is stored in the memory-11. This is repeated for the pulse wave recorded in ST20. ST2
The basal pulse rate RR 0E is calculated by taking the average of the basal pulse rate of each pulse wave calculated in 514.
【0023】図2に戻り、説明する。ステップST26
にて求めた基底脈拍数から基底血圧値を計算する。図4
に基底血圧値計算の詳細フロ−チャ−トを示す。ステッ
プST261にて、臨床にて収集した複数個の脈波波形
と同じ被験者にて、別の方法で検出した複数個の基底血
圧デ−タを多変量解析することによりα、βの各定数を
設定した式 拡張期血圧の基底血圧Pd0=Pd/EX
P(A(RR0E−RR))−(α*Pd/脈拍数−
(β+Ps/脈拍数));α=45、β=15を用い、
拡張期血圧の基底血圧を今までに求めたPd、脈波形形
状パラメ−タA、RR0E、RR、脈拍数、Psを代入
して計算する。Returning to FIG. 2, description will be made. Step ST26
The basal blood pressure value is calculated from the basal pulse rate obtained in. Figure 4
The detailed flowchart of the calculation of the basal blood pressure value is shown in FIG. In step ST261, a plurality of basal blood pressure data detected by another method are multivariately analyzed in the same subject as a plurality of pulse wave waveforms collected clinically to determine each constant of α and β. Set expression Diastolic blood pressure basal blood pressure Pd 0 = Pd / EX
P (A (RR 0E −RR)) − (α * Pd / pulse rate−
(Β + Ps / pulse rate)); using α = 45 and β = 15,
The basal blood pressure of the diastolic blood pressure is calculated by substituting Pd, pulse waveform shape parameter A, RR 0E, RR, pulse rate, and Ps obtained so far.
【0024】基底血圧Pd0の第1項は、基底脈拍数と
末梢血管抵抗と血管弾性が作用する項、第2項は圧受容
体反射の感受性に関係する項である。ステップST26
2にては、同様に、臨床にて収集した複数個の脈波波形
と同じ被験者にて、別の方法で検出した複数個の基底血
圧デ−タを多変量解析することによりBとγの各定数を
設定した式である 収縮期血圧の基底血圧Ps0=Pd
0*EXP(B(RR 0E−u0E))+γ:B=0.5*
m/RR;γ=30を用い、この式にこれまでに求めた
m、Pd0、RR0E、U0、を代入して、収縮期血圧の
基底血圧を計算する。さらに、ステップST263にて
いままでに求めた拡張期血圧の基底血圧Pd0、収縮期
血圧の基底血圧Ps0、を式 平均血圧の基底血圧MB
P0=(Ps0−Pd0)/3+Pd0に代入して基底血圧
を計算する。Basal blood pressure Pd0The first term of is the basal pulse rate and
Peripheral vascular resistance and vascular elasticity act, the second term is baroreception
This is a term related to the sensitivity of body reflex. Step ST26
Similarly, in 2, the multiple pulse wave waveforms collected clinically
Multiple basal blood detected by another method in the same subject as
By performing multivariate analysis on the pressure data, the constants of B and γ can be calculated.
The set expression is the basal blood pressure Ps of the systolic blood pressure.0= Pd
0* EXP (B (RR 0E-U0E)) + Γ: B = 0.5 *
m / RR; γ = 30 was used and this formula was used to obtain
m, Pd0, RR0E, U0,Substituting for systolic blood pressure
Calculate basal blood pressure. Furthermore, in step ST263
Basal blood pressure Pd of diastolic blood pressure obtained so far0,Systole
Basal blood pressure Ps of blood pressure0,The mean blood pressure is the basal blood pressure MB
P0= (Ps0-Pd0) / 3 + Pd0Substituting into
To calculate.
【0025】図2に戻ってステップST27にて白衣性
高血圧検出を行う。図5に白衣性高血圧検出(判断)の詳
細フロ−チャ−トを示す。ステップST271におい
て、平均血圧の基底血圧MBP0が89mmHgより大きい
場合には、高血圧症の可能性があるので白衣性高血圧で
ないと判断して,ステップST273にて白衣性高血圧
表示フラッグを0のままにし、89以下の場合には、正
常血圧であるので、白衣性高血圧であると判断して、ス
テップST272にて白衣性高血圧表示フラッグを1に
する。Returning to FIG. 2, white coat hypertension is detected in step ST27. FIG. 5 shows a detailed flowchart for detecting (determining) white coat hypertension. In step ST271, if the basal blood pressure MBP 0 of the mean blood pressure is higher than 89 mmHg, it is possible that hypertension may occur, so it is determined that the white coat hypertension is not present, and the white coat hypertension display flag is left at 0 in step ST273. , 89 or less, it means that the blood pressure is normal, so that it is determined that the blood pressure is high, and the white blood pressure display flag is set to 1 in step ST272.
【0026】図2に戻って、ステップST28にて表示
器12に収縮期血圧値、拡張期血圧値を表示し、ステッ
プST29にて基底血圧値(収縮期、拡張期、平均血
圧)を表示し、ステップST30にての白衣性高血圧検
出され白衣性高血圧表示フラッグが1の場合、表示器1
2に「白衣性高血圧の可能性アリ」の表示を行う。白衣
性高血圧表示フラッグ0の場合には何も表示をしない。
続いて、ステップST31にて脈拍数が表示され一連の
動作を終了する。Returning to FIG. 2, the systolic blood pressure value and the diastolic blood pressure value are displayed on the display device 12 in step ST28, and the basal blood pressure value (systole, diastole, mean blood pressure) is displayed in step ST29. If the white coat hypertension is detected in step ST30 and the white coat hypertension display flag is 1, the indicator 1
The display of "possibility of white coat hypertension" is displayed on 2. When the white coat hypertension display flag is 0, nothing is displayed.
Then, in step ST31, the pulse rate is displayed and a series of operations is completed.
【0027】[0027]
【発明の効果】本発明の請求項第1項〜第7項、及び第
10項に記載の発明よれば、現行の基底血圧の測定であ
るカフを用いた血圧計を24時間装着する方法は、腕に
常にカフが装着され拘束された状態にあり、かつ、24
時間で70〜100回の定期的な測定が必要でそのたび
に腕が締め付けられ苦痛であること、また、夜間は、安
眠が妨害される場合があること、また、ポンプ駆動音に
より周囲の人迷惑をかけるとともに、測定していること
がわかってしまうことにより、患者に肉体的、精神的な
大きな負担が掛かるという欠点を有する。According to the inventions described in claims 1 to 7 and 10 of the present invention, a method for wearing a sphygmomanometer using a cuff, which is the current measurement of basal blood pressure, for 24 hours is as follows: , The cuff is always attached to the arm and is restrained, and
It requires 70 to 100 regular measurements in time, and each time the arm is tightened and it is painful, and at night, sleep may be disturbed. There is a drawback in that the patient is physically and mentally burdened by the fact that the measurement is known as well as annoying.
【0028】さらに、現状では24時間装着する血圧計
を用いた場合、就寝時にも腕を阻血する必要があり、腕
の締め付け、加圧ポンプ音により安眠が妨げられ血圧が
高くなる欠点、および、腕の締め付け、加圧ポンプの騒
音による体動が発生し、そのア−チファクトにより正確
な血圧測定が妨げられる測定精度上の欠点も有するが、
本発明によれば、通常の1回の血圧測定にて基底血圧が
測定できこれらの患者負担が大きく、精度が悪い欠点を
排除できる。また、本発明によれば、現行の基底血圧測
定法であるカフを用いる方法では、比較的安全である
が、原理的に一日10万回以上の血圧値を全て測定する
ことができないので確度が悪いという欠点。一方、観血
血圧計を装着する方法では、1日10万回の血圧値の測
定は可能であるが、Aラインを動脈に入れる必要があ
り、非常に危険であり管理が行き届いた医療機関でしか
行えない欠点を有する。これに対して、本発明では、安
全で精度の高い基底血圧測定が可能な血圧計の実現が可
能である。Further, in the present situation, when a sphygmomanometer that is worn for 24 hours is used, it is necessary to block blood in the arm even at bedtime, and a problem that blood pressure becomes high due to interference with sleep due to tightening of the arm and sound of pressure pump, and Tightening of the arm, body movement due to the noise of the pressure pump occurs, and there is a drawback in measurement accuracy that an accurate blood pressure measurement is hindered by the artifact, but
According to the present invention, the basal blood pressure can be measured by a single normal blood pressure measurement, and these patient burdens are large and defects with poor accuracy can be eliminated. Further, according to the present invention, the method using a cuff, which is the current basal blood pressure measurement method, is relatively safe, but in principle, it is not possible to measure all blood pressure values of 100,000 or more times a day, and therefore the accuracy is high. The disadvantage is that is bad. On the other hand, with the method of wearing the sphygmomanometer, it is possible to measure the blood pressure 100,000 times a day, but it is necessary to insert the A line into the artery, which is very dangerous and is a well-managed medical institution. It has the drawback that it can only be done. On the other hand, according to the present invention, it is possible to realize a sphygmomanometer that can measure the basal blood pressure safely and with high accuracy.
【0029】通常の高血圧診療において、白衣性高血圧
が疑われた場合の確認検査には、患者が落ちつくまで待
って再度血圧測定を行う必要があり、診療治療に時間を
要する。また、カフを用いた血圧計を24時間装着する
場合には、基底血圧の測定と同様の課題が発生する。本
発明では、通常と同じ1回の血圧測定で白衣性高血圧の
検出が行え、患者が落ちつくのを待っている必要がなく
次の対応がすぐ実施でき、かつ、疑似高血圧による誤っ
た診断を防止でき、高血圧症の正しい診断がスピ−ディ
に実施可能となる。In normal hypertensive medical care, a confirmation test in the case of suspected white coat hypertension requires waiting for the patient to settle down and measuring the blood pressure again, which requires time for medical treatment. Further, when a blood pressure monitor using a cuff is worn for 24 hours, the same problem as in the measurement of basal blood pressure occurs. In the present invention, white coat hypertension can be detected by the same single blood pressure measurement as usual, the next action can be performed immediately without waiting for the patient to settle down, and false diagnosis due to pseudo-hypertension can be prevented. Therefore, a correct diagnosis of hypertension can be speedily implemented.
【0030】請求項第8項に記載の発明によれば、減圧
ストップによる圧力系が一時的に不安定な状態なること
による脈波検出への悪影響が防止しできる。また、請求
項第9項に記載の発明によれば、短時間の測定により、
減圧ストップしてから、カフ末梢側血管への血液プ−リ
ング量の増加による脈波検出系のコンプライアンス増加
による脈波検出品質の低下の防止、また、鬱血による生
理的な苦痛の防止効果がある。According to the eighth aspect of the invention, it is possible to prevent the adverse effect on the pulse wave detection due to the temporary destabilization of the pressure system due to the decompression stop. Further, according to the invention of claim 9, by measuring in a short time,
After decompression is stopped, there is an effect of preventing deterioration of pulse wave detection quality due to an increase in compliance of the pulse wave detection system due to an increase in blood pulling amount to the cuff peripheral blood vessel and a physiological distress due to congestion. .
【図1】 本発明の実施例のブロック図である。FIG. 1 is a block diagram of an embodiment of the present invention.
【図2】 本発明の実施例の動作フロ−チャ−トであ
る。FIG. 2 is an operation flow chart of the embodiment of the present invention.
【図3】 本発明の実施例の基底脈拍数計算手段のフロ
−チャ−トである。FIG. 3 is a flowchart of the basal pulse rate calculating means of the embodiment of the present invention.
【図4】 本発明の実施例の白衣性高血圧検出のフロ−
チャ−トである。FIG. 4 is a flow chart for detecting white coat hypertension according to the embodiment of the present invention.
It is a chart.
【図5】 本発明の実施例の白衣性高血圧検出(判断)の
詳細フロ−チャ−トを示す。FIG. 5 shows a detailed flowchart of detection (judgment) of white coat type hypertension according to the embodiment of the present invention.
1…阻血用のカフ、2…脈波検出用のカフ、5…圧力セ
ンサ−、6…加圧ポンプ、7…排気兼定速減圧バルブ、
10…MPUDESCRIPTION OF SYMBOLS 1 ... Cuff for blood flow prevention, 2 ... Cuff for pulse wave detection, 5 ... Pressure sensor, 6 ... Pressurization pump, 7 ... Exhaust and constant-speed decompression valve,
10 ... MPU
Claims (10)
加圧手段と減圧する減圧手段と、 該カフ帯内の流体圧を検出する圧力検出手段と、 該カフ帯装着部位の脈波を検出する脈波検出手段と、 圧力検出手段で検出した流体圧と脈波検出手段で検出し
た脈波に基づいて血圧値を決定する血圧決定手段と、 カフ圧を血圧決定手段で決定した拡張期血圧より所定圧
低い一定圧にホールドするカフ圧ホ−ルド手段と、 基底脈拍数を計算する基底脈拍数計算手段と、 基底血圧を計算する基底血圧計算手段と、 白衣性高血圧判断手段を有することを特徴とする血圧
計。1. A cuff band and a pressurizing unit for pressurizing a fluid in the cuff band, a depressurizing unit for depressurizing the cuff band, a pressure detecting unit for detecting a fluid pressure in the cuff band, and a pulse wave at a site where the cuff band is attached. Pulse wave detecting means for detecting the blood pressure, a blood pressure determining means for determining a blood pressure value based on the fluid pressure detected by the pressure detecting means and a pulse wave detected by the pulse wave detecting means, and an expansion for determining the cuff pressure by the blood pressure determining means. It has a cuff pressure-holding means for holding a constant pressure lower than the term blood pressure, a basal pulse rate calculating means for calculating a basal pulse rate, a basal blood pressure calculating means for calculating a basal blood pressure, and a white coat hypertension determining means. A blood pressure monitor characterized by that.
手段の出力と、脈波形状パラメ−タ測定手段の出力と、
アップストロ−ク検出手段の出力と、該血圧決定手段の
出力を用いることを特徴とする請求項第1項に記載の血
圧計。2. The basal pulse rate calculating means includes an output of the pulse wave interval measuring means and an output of the pulse wave shape parameter measuring means,
2. The sphygmomanometer according to claim 1, wherein the output of the up stroke detecting means and the output of the blood pressure determining means are used.
計算手段の出力と、波形形状パラメ−タ検出手段の出力
と、脈波間隔測定手段の出力と、該血圧決定手段の出力
とアップストロ−クタイム検出手段の出力を用いること
を特徴とする請求項第1項に記載の血圧計。3. The basal blood pressure value calculating means outputs the output of the basal pulse rate calculating means, the output of the waveform shape parameter detecting means, the output of the pulse wave interval measuring means, and the output of the blood pressure determining means. The sphygmomanometer according to claim 1, wherein the output of the up stroke time detecting means is used.
計算手段の出力と、ある規定値を比較して白衣性高血圧
を判断することを特徴とする特許請求項1に記載の血圧
計。4. The sphygmomanometer according to claim 1, wherein the white coat hypertension judging means judges white coat hypertension by comparing an output of the basal blood pressure calculating means with a predetermined value.
脈波ピ−クからボトムに到る減衰特性を検出することを
特徴とする特許請求項1または請求項2のいずれかに記
載の血圧計。5. The waveform shape parameter detecting means,
The sphygmomanometer according to claim 1 or 2, wherein an attenuation characteristic from the pulse wave peak to the bottom is detected.
した本考案の血圧計により検出した脈波波形および別の
方法で検出した基底血圧デ−タを多変量解析することに
より複数の定数を設定する手段を含むことを特徴とする
特許請求項第1項の血圧計。6. The basal pulse rate calculating means performs multivariate analysis of a plurality of clinically collected pulse wave waveforms detected by the sphygmomanometer of the present invention and basal blood pressure data detected by another method to obtain a plurality of values. The sphygmomanometer according to claim 1, further comprising means for setting a constant.
した本考案の血圧計により検出した脈波波形および別の
方法で検出した基底血圧デ−タを多変量解析することに
より複数の定数を設定する手段を含むことを特徴とする
特許請求項第1項に記載の血圧計。7. The basal blood pressure value calculating means performs multivariate analysis of a plurality of pulse wave waveforms detected by the sphygmomanometer of the present invention collected clinically and basal blood pressure data detected by another method to obtain a plurality of values. The blood pressure monitor according to claim 1, further comprising means for setting a constant.
検出手段が、減圧を中止してから、脈波検出を開始する
までに脈波を検出しない所定の時間を設けたことを特徴
とする特許請求項第1項に記載の血圧計。8. A predetermined time during which the pulse wave is not detected by the pulse wave detecting means when the pressure is held at a constant pressure and before the pulse wave detection is started after the pressure reduction is stopped. The blood pressure monitor according to claim 1, wherein:
秒以内であることを特徴とする特許請求項第1項に記載
の血圧計。9. The sphygmomanometer according to claim 1, wherein the time for holding at a constant pressure is within a predetermined second.
と、拡張期血圧の基底血圧と、平均血圧の基底血圧であ
ることを特徴とする特許請求項1に記載の血圧計。10. The sphygmomanometer according to claim 1, wherein the basal blood pressure values are a basal blood pressure of systolic blood pressure, a basal blood pressure of diastolic blood pressure, and a basal blood pressure of average blood pressure.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002072865A JP2003265420A (en) | 2002-03-15 | 2002-03-15 | Hemodynamometer with arterial pressure pulse wave analyzing function using brachium pressurizing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002072865A JP2003265420A (en) | 2002-03-15 | 2002-03-15 | Hemodynamometer with arterial pressure pulse wave analyzing function using brachium pressurizing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2003265420A true JP2003265420A (en) | 2003-09-24 |
Family
ID=29202742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002072865A Pending JP2003265420A (en) | 2002-03-15 | 2002-03-15 | Hemodynamometer with arterial pressure pulse wave analyzing function using brachium pressurizing method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003265420A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007068631A (en) * | 2005-09-05 | 2007-03-22 | A & D Co Ltd | Quantitative pulsation generator |
| JP2009011585A (en) * | 2007-07-05 | 2009-01-22 | Toshiba Corp | Pulse wave processing apparatus and method |
| WO2020026647A1 (en) * | 2018-07-31 | 2020-02-06 | 株式会社パラマ・テック | Automatic blood pressure measurement device |
-
2002
- 2002-03-15 JP JP2002072865A patent/JP2003265420A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007068631A (en) * | 2005-09-05 | 2007-03-22 | A & D Co Ltd | Quantitative pulsation generator |
| JP2009011585A (en) * | 2007-07-05 | 2009-01-22 | Toshiba Corp | Pulse wave processing apparatus and method |
| WO2020026647A1 (en) * | 2018-07-31 | 2020-02-06 | 株式会社パラマ・テック | Automatic blood pressure measurement device |
| CN110772242A (en) * | 2018-07-31 | 2020-02-11 | 北京太阳升高科医药研究股份有限公司 | Automatic blood pressure measuring device with autonomic nerve analysis function |
| JPWO2020026647A1 (en) * | 2018-07-31 | 2021-08-02 | 株式会社パラマ・テック | Automatic blood pressure measuring device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6602199B2 (en) | Method and apparatus for measuring values of physiological parameters | |
| US6338719B1 (en) | Method and system for detecting vascular conditions using an occlusive arm cuff plethysmograph | |
| US5533511A (en) | Apparatus and method for noninvasive blood pressure measurement | |
| US7309313B2 (en) | Vascular disease examining system and bypass vascular diagnosing device | |
| JP5410210B2 (en) | Artifact removal method, blood volume measuring device and artifact removal program in respiratory stroke fluctuation analysis device for stroke volume | |
| JP5330069B2 (en) | Blood volume measuring method, blood volume measuring apparatus and blood volume measuring program | |
| JP5432765B2 (en) | Blood volume measuring device and method for evaluating measurement results of blood volume measuring device | |
| RU2508904C1 (en) | Method and device for evaluating risk of cardiovascular complications | |
| US20060178585A1 (en) | Non-invasive measurement of suprasystolic signals | |
| JPH11347004A (en) | Method and apparatus for measuring blood pressure not inserted into body and method and apparatus for detecting arrhythmia | |
| US6440080B1 (en) | Automatic oscillometric apparatus and method for measuring blood pressure | |
| JP4702216B2 (en) | Electronic blood pressure monitor and control method thereof | |
| US20150105634A1 (en) | Monitoring Cardiovascular Conditions Using Signal Transit Times | |
| WO2010026862A1 (en) | Electronic sphygmomanometer and method for controlling blood pressure measurement | |
| US6517495B1 (en) | Automatic indirect non-invasive apparatus and method for determining diastolic blood pressure by calibrating an oscillation waveform | |
| KR101604078B1 (en) | Blood pressure monitoring apparatus and method of low pressurization | |
| JP4668421B2 (en) | Method and apparatus for continuous analysis of cardiovascular activity of a subject | |
| JP2001008907A (en) | Electric sphygmomanometer | |
| JP3818853B2 (en) | Electronic blood pressure monitor | |
| JP2003265420A (en) | Hemodynamometer with arterial pressure pulse wave analyzing function using brachium pressurizing method | |
| JP3057933B2 (en) | Electronic sphygmomanometer | |
| CN211883777U (en) | Korotkoff sound-based blood pressure measurement and cardiovascular system evaluation system | |
| US20030167011A1 (en) | Standard pulse-wave-propagation-velocity-related-value determining apparatus and pulse-wave-propagation-velocity-related-value obtaining apparatus | |
| CZ306567B6 (en) | A method of precise automatic non-invasive sensing of a blood pulse wave and a device for performing this method | |
| JP2003230541A (en) | Superior limb-inferior limb blood pressure index- measuring system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050215 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060807 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070220 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070418 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070529 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070626 |